 |
Medscape Conference Coverage, based on selected sessions at the: 65th Scientific Sessions of the American Diabetes Association June 10 - 14, 2005, San Diego, California
This activity is not sanctioned by, nor a part of, the American Diabetes Association.
|
| Topic Overviews | |
| The Metabolic Syndrome CME/CEPhysicians - up to 2.0 hour(s) of AMA PRA category 1 credit;
Registered Nurses - up to 2.4 Nursing Continuing Education contact hour(s)
Pharmacists - up to 1.75 contact hour(s) (0.175 CEUs)| • | The Broadening Domain of the Metabolic Syndrome
Anne Peters, MD | | • | Clinical Management of the Metabolic Syndrome
David M. Kendall, MD | | • | Natural History of the Metabolic Syndrome and Type 2 Diabetes: The Ticking Clock
Aaron I. Vinik, MD, PhD |
The Incretin Hormones CME/CEPhysicians - up to 1.25 hour(s) of AMA PRA category 1 credit;
Registered Nurses - up to 1.4 Nursing Continuing Education contact hour(s)
Pharmacists - up to 1.25 contact hour(s) (0.125 CEUs)| • | Exenatide
Charles H. Choe, MD; Steven V. Edelman, MD | | • | GLP-1 Analogs Other Than Exenatide
Laurie L. Baggio, MSc, PhD; Daniel J. Drucker, MD | | • | Therapeutic Potential of the DPP-IV Inhibitors
Tanya Hansotia, BSc; Daniel J. Drucker, MD |
Microvascular Complications CME/CEPhysicians - up to 1.0 hour(s) of AMA PRA category 1 credit;
Registered Nurses - up to 1.2 Nursing Continuing Education contact hour(s)
Pharmacists - up to 1.0 contact hour(s) (0.1 CEUs)| • | Focus on Diabetic Retinopathy
Hans-Peter Hammes, MD, PhD | | • | The Diabetic Foot: Putting Feet First
Lawrence A. Lavery, DPM, MPH |
|
| | | Expert Interview | |
|
| Conference News | |
|
| Legal Disclaimer | |
| The materials presented here were prepared by independent authors under the editorial supervision of Medscape and do not represent a publication of the American Diabetes Association. These materials and the related activity are not sanctioned by the American Diabetes Association or the commercial supporter of the conference, and do not constitute an official part of that conference. The materials presented here do not reflect the views of Medical Education Collaborative, Nurse Practitioner Alternative, Medscape or the companies providing unrestricted educational grants. These materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. All readers or continuing education participants should verify all information and data before treating patients or employing any therapies described in this educational activity. Copyright © 2005 Medscape. |
|
|
|
